Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 3
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Machine Learning Predicts Cardiovascular Events in Patients With Diabetes: The Silesia Diabetes-Heart Project.
Nabrdalik K, Kwiendacz H, Drożdż K, Irlik K, Hendel M, Wijata AM, Nalepa J, Correa E, Hajzler W, Janota O, Wójcik W, Gumprecht J, Lip GYH. Nabrdalik K, et al. Among authors: drozdz k. Curr Probl Cardiol. 2023 Jul;48(7):101694. doi: 10.1016/j.cpcardiol.2023.101694. Epub 2023 Mar 14. Curr Probl Cardiol. 2023. PMID: 36921649 Free article. Review.
Clinical Trial: Probiotics in Metformin Intolerant Patients with Type 2 Diabetes (ProGasMet).
Nabrdalik K, Drożdż K, Kwiendacz H, Skonieczna-Żydecka K, Łoniewski I, Kaczmarczyk M, Wijata AM, Nalepa J, Holleman F, Nieuwdorp M, Gumprecht J. Nabrdalik K, et al. Among authors: drozdz k. Biomed Pharmacother. 2023 Dec;168:115650. doi: 10.1016/j.biopha.2023.115650. Epub 2023 Oct 7. Biomed Pharmacother. 2023. PMID: 37812890 Free article. Clinical Trial.
Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart Project.
Nabrdalik K, Kwiendacz H, Irlik K, Hendel M, Drożdż K, Wijata AM, Nalepa J, Janota O, Wójcik W, Gumprecht J, Lip GYH. Nabrdalik K, et al. Among authors: drozdz k. Cardiovasc Diabetol. 2023 Nov 20;22(1):318. doi: 10.1186/s12933-023-02014-z. Cardiovasc Diabetol. 2023. PMID: 37985994 Free PMC article.
Influence of SGLT2 Inhibitor Treatment on Urine Antioxidant Status in Type 2 Diabetic Patients: A Pilot Study.
Nabrdalik-Leśniak D, Nabrdalik K, Sedlaczek K, Główczyński P, Kwiendacz H, Sawczyn T, Hajzler W, Drożdż K, Hendel M, Irlik K, Stelmach P, Adamczyk P, Paradysz A, Kasperczyk S, Stompór T, Gumprecht J. Nabrdalik-Leśniak D, et al. Among authors: drozdz k. Oxid Med Cell Longev. 2021 Jul 14;2021:5593589. doi: 10.1155/2021/5593589. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34336104 Free PMC article.